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Abstract 
Purpose (mandatory) The present study develops a conceptual model that examines the 
underlying mechanisms of the link between the uses of corporate reputation and brand image 
strategy, from the corporate communication perspective. The study incorporates three kinds 
of uses of corporate reputation: value creation, strategic resources and corporate 
communication.   
 
Design/methodology/approach (mandatory) Using a qualitative approach, in-depth 
interviews were conducted with top executives in the pharmaceutical industry in Taiwan to 
investigate the effects of the uses of corporate reputation on brand image strategy from the 
managerial perspective.  
 
Findings (mandatory) Findings provide richness into forming the basis for developing a 
framework of the uses of reputation, with implications for managers and academics alike. 
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The qualitative findings generally showed that three dimensions of the uses of corporate 
reputation (i.e. value creation, strategic resources and corporate communication) are 
applicable to managers’ brand image strategy implementation. For the Taiwanese 
pharmaceutical industry, the research highlights that value creation herein pertains to the 
value created for the firm, as (a) cost/sacrifice value, (b) symbolic/expressive value, and (c) 
experience/hedonic value. 
 
Originality/value (mandatory) Reputation is one of the most important concerns for 
pharmaceutical firms, as it develops and builds trust with key stakeholders. However, in the 
pharmaceutical industry context, the application and uses of corporate reputation is little 
researched. A need exists for research that examines the effects of the uses of corporate 
reputation at the firm level. This study fills this important gap in developing a conceptual 
framework for the uses of corporate reputation in the pharmaceutical industry. In addition, 
most studies on the uses of corporate reputation in pharmaceuticals are in the contexts of 
Western countries, thus, limiting the generalisablility. Taiwan is the context for the present 
study. 
 
Keywords: Reputation, brand image, value creation, strategic resources, corporate 
communication, pharmaceutical industry, Taiwan. 
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Introduction 
In the pharmaceutical industry, organizations are complex and subject to a number of 
critical influences, such as regulations and directives, meaning that pharmaceuticals need to 
actively consider how key stakeholders perceive them. Managers play a particularly 
important role in building a firm’s reputation and brand image (Miller, 2014), as the 
pharmaceutical brand is built to gain trust from professionals such as physicians and doctors. 
For example, when managers target their brands to large, well-reputed customers and niche 
markets with top quality products, these decision makers are highly influential in the 
representation of the pharmaceutical company and its brand towards its customers. Thus, in 
the brand development and management strategy, for these pharmaceuticals, intangible assets 
such as corporate reputation play a crucial role to attain competitive advantage (Hatch and 
Schultz, 2001; Rao et al., 2004; Tran et al., 2015).  
Although separate studies are available on corporate reputation and on how a 
pharmaceutical company builds or extends its corporate brand (e.g. Argenti et al., 2005), very 
few studies, linking corporate branding and reputation, are available, and these studies are not 
specific on how firms use their corporate reputation to give more strategic insights to its 
brand. Dolphin’s (2004) study seems to be the most relevant study, giving a review of how 
firms put the reputation idea into the branding process. However, the concept of the uses of 
corporate reputation in pharmaceuticals still remains unclear as most of the studies regarding 
this issue were conducted solely from customer perspectives. There is the need for more 
research that examines the effects of uses of corporate reputation at the firm and management 
level, raising the question of the applicability of the uses of corporate reputation in the 
pharmaceutical industry context. Thus, to fill a much needed gap, the present study 
investigates further the uses of corporate reputation from a managerial perspective and 
focuses on three kinds of corporate reputation uses, derived from our extensive review of the 
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literature, namely, value creation, strategic resources and corporate communication (e.g., 
Chen and Otubanjo, 2014). In addition, most studies on the uses of corporate reputation in 
pharmaceuticals have been conducted in Western countries, such as the USA, the UK and 
Germany, thus, limiting the generalisablility. In order to bridge this gap, Taiwan, as a country 
in far eastern Asia, has therefore been selected as the setting of this study. The research 
question is expressed as follows: How do Taiwanese pharmaceutical companies use their 
corporate reputation to develop a brand image strategy?  
Aiming to examine how pharmaceutical managers make brand decisions based on 
corporate reputation using the unique context of Taiwan, the study contributes to the brand 
management literature in the following areas: (1) First, the research advances current 
knowledge by providing alternative insights from practitioners to the uses of corporate 
reputation. The study adds views from top management executives on the uses of corporate 
reputation to possible outcomes of a brand image strategy. (2) Second, relevant mechanisms 
underlying the relationships between the uses of corporate reputation and the design of a 
brand image strategy are investigated in a non-Western context. That is, the research shows 
how each dimension of the uses of corporate reputation affects the design of brand image 
strategy in the pharmaceutical industry in Taiwan. Implications exist as to how managers 
may use corporate reputation in a more specific branding-oriented approach in the 
pharmaceutical industry. 
The rest of the article is arranged as follows:  First, we review the literature on 
corporate reputation and its concepts. Following this is a presentation of the method and data 
analysis employed. Subsequently, we present and critically discuss our findings from the 
qualitative study. Finally, we conclude the present study on reputation with implications for 
theory and practice, and offer directions for future research. 
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Literature review 
One of the most cited definitions of corporate reputation was put forward by Weigelt 
and Camerer (1988) in the strategic management field. These authors argued that corporate 
reputation is an attribute or a set of attributes ascribed to a firm and inferred from the firm’s 
past actions.  In other words, corporate reputation is the belief of market participants about a 
firm’s strategic character (Weigelt and Camerer, 1988). Another important definition, which 
has been cited in many works is that presented in the work of Roberts and Dowling (2002). 
They contend that corporate reputation is the public’s cumulative judgement of firms, over 
time. Researchers have discussed corporate reputation as a history of customer perception 
about the firm, such as the collective beliefs that exist in the organisational field about a 
firm’s identity and prominence (Rao, 1994; Rindova and Kotha, 2001), media visibility and 
the business favour gained by a firm (Deephouse, 2000).   
In the branding literature, corporate reputation is also found as a signal of a firm’s 
actions to its customers (i.e., Fombrun and Shanley, 1990; Herbig et al., 1994). Brand 
managers send, seek for and interpret cues to try to understand the beliefs, attitudes, or 
intentions of market participants (Herbig and Milewicz, 1993). According to attitude theories 
such as the expectancy-value theory (Fishbein and Ajzen, 1975), market participants (e.g. 
consumer, retailer, supplier, etc.) make decisions by selecting the alternative which is 
perceived to be most promising and is likely to lead to the most favourable outcomes for 
them. Consistent positive signals about a company’s products or services quality can enhance 
its credibility (Herbig et al., 1994) and positively influence customers’ attitudes as well as 
purchase intentions (e.g. Campbell, 1999; Goldberg and Hartwick, 1990). In contrast, less 
positive or negative signals can render opposite results, especially when signals are sent out 
inconsistently (e.g. LaBarbera, 1982). 
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An extensive review of the theoretical literature from various academic areas (i.e. 
public relations, marketing, management, economic, sociological, finance and accounting) 
indicates a strong overlap in the theoretical concept building of the uses of the concept of 
corporate reputation among business organizations. Attention is drawn to the emergence of a 
number of conceptual overlaps in the literature concerning use of corporate reputation. 
Mainly, the uses of corporate reputation are categorized into three groups: value creation, the 
influence on competitor’s actions and the development of relationships with stakeholders.  
 
Value creation. Scholars state that corporate reputation is used and presented to stakeholders 
as a corporate valuable or as an intangible asset that creates value in the future (Fombrun, 
1996). Dierickx and Cool (1989) contend that corporate reputation is used as an asset, which 
cannot be bought, and thus is not easy to imitate or substitute.  
 
Strategic resource. Roberts and Dowling (2002) claim that corporate reputation is 
commonly used as a defence strategy to ward off competitors. Moreover, corporate 
reputation is commonly used as a means of highlighting and signifying (Herbig and 
Milewicz, 1993) a firm’s beliefs, attitudes and intentions to market participants – and thus 
interpreted by stakeholders. Consequently, firms aspire to achieve competitive advantage by 
deploying strategies that will effectively differentiate them from competitors (Beatty and 
Ritter, 1986).  
 
Corporate communication. Lerbinger (1965) argues that corporate reputation is used to 
communicate a firm’s social responsibility activities to stakeholders within the business 
environment. Moreover, corporate reputation is used as a means of shaping the perception of 
shareholders and stakeholders, suggesting that a firm’s corporate reputation commonly 
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shapes the opinions and perceptions of shareholders and stakeholders alike (Brammer and 
Pavelin, 2006). 
 
On the whole, our review of the literature indicates that corporate reputation is drawn 
to protect firms from excessive interpretation among stakeholders. It is observed that a 
corporate reputation helps customers to select the best choice among many alternatives in the 
market and serves as a value signal that enables customers to gauge the merits of a product or 
service, especially in situations where customers are overloaded with information or in cases 
where there is inadequate information about a product (Fombrun and Shanley, 1990; Fryxell 
and Wang, 1994). Fombrun and Shanley (1990) indicate that corporate reputation is used for 
influencing consumer choices. Scholars support this idea, arguing that corporate reputation is 
used by consumers to make purchasing decisions (Landon and Smith, 1997) and contend that 
a good corporate reputation enables the generation of increased customer loyalty (Eberl and 
Schwaiger, 2005; Roberts and Dowling, 2004). 
Based on the literature review, the study identifies three major gaps in the general 
management literature, namely that (1) few studies link corporate branding and the uses of 
reputation, specifying on how firms use their corporate reputation to give more strategic 
insights to its brand (Dolphin, 2004), (2) the concept of the uses of corporate reputation still 
remains unclear as most of the studies were conducted solely from customer perspectives, 
and not from the managerial perspective, and (3) most studies on the uses of corporate 
reputation in pharmaceuticals have been conducted in Western countries, such as the USA, 
the UK and Germany, thus, limiting the generalisablility. The present study explicitly aims to 
address these gaps. In the subsequent sections, the uses of corporate reputation are explored 
in the pharmaceutical industry in Taiwan, followed by discussions and implications for 
management. The methodology behind this exploration is presented next. 
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Method 
Research setting 
The pharmaceutical industry was chosen because reputation building is particularly 
important for senior executives in pharmaceutical firms. Medicines are vital for human life 
and the trust arising from corporate reputation thus plays an important role in the general 
perception among individuals. Furthermore, a pharmaceutical firm can use its reputation to 
signal to its customers about its new technology, the standards they require, or just to build 
trust within its customers.  
In accordance with the research objective, the researchers intend to empirically test 
the model in a non-Western setting in order to examine the validity of Western-developed 
theories. Taiwan has been selected as the setting of this study because its oriental culture 
(which is mainly followed by Chinese culture) is clearly different from Western culture 
(Hofstede, 1980). For example, with regard to the distribution of power, Taiwan has higher 
inequality between people and organizations than those most developed countries (Hofstede, 
1980). In addition, compared to developed countries, Taiwanese have high uncertainly 
avoidance, implying that Taiwanese people have a higher tolerance for ambiguity, and less 
emotional resistance to change. Taiwan has a very low score for individualism when 
compared to Western countries (Hofstede, 1980). In addition, the values and norms of 
Taiwanese employees have a strong root in Buddhism and Taoism, which is different from 
those in Western countries, which are mainly Christian–Catholicor Protestant (Hofstede, 
1980).   
The Taiwanese generic medicine market is getting stronger and more solid. In the 
1990s, Taiwan pharmaceutical companies were consistently among the top ten-ranked in the 
US market. In the past few years, many companies have been turning to Taiwan to seek new 
technologies and to reduce costs. This indicates that Taiwan’s own pharmaceutical industry 
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technology has greatly improved and is reaching international standards (Swinbanks and 
Cyranoski, 2000). This trend in turn encourages competition in the Taiwanese pharmaceutical 
industry. Companies in Taiwan, especially in the pharmaceutical industry, therefore 
increasingly recognise the importance of the uses of a firm’s reputation.   
 
Data collection and sample 
Qualitative research is more suitable when there is a need for unfolding what 
surrounds a phenomenon (Carson et al., 2001). A considerable number of studies have used 
qualitative methods to gain insights into the reputation phenomena being investigated (e.g. 
Arnould and Price, 1993; McGuire et al., 1990; Thompson, 1997; Weigelt and Camerer, 
1988). The objective of this study is to investigate the effects of the uses of corporate 
reputation on brand image strategy in the pharmaceutical industry from the managerial 
perspective. The research was conducted using in-depth interviews with managers in the 
pharmaceutical industry in Taiwan. Fourteen brand managers from pharmaceutical 
companies in Taiwan participated as respondents. These respondents were selected because 
they have experience in implementing brand segmentation and positioning strategies in their 
pharmaceutical company and were able to provide information about how their firms’ current 
situation affect the corporate brand strategy. Following the literature search to generate and 
develop the interview questions, a guide was developed and in-depth interviews with experts 
were conducted. A list of questions was designed on the basis of the reviewed literature and 
the research question, consisting of several open-ended questions (see Table 1 for the full 
list). The following protocol was used: First, following a brief presentation of the study, each 
topic, as identified from the literature were presented, and the interviewees were allowed to 
talk freely about their experiences. The profile of interviewees and details about interviews 
appear in Table 2.  
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< Insert Table 1 About Here > 
< Insert Table 2 About Here > 
 
 Following Miles and Huberman (1994), the researchers extracted themes from the 
interview data by using data reduction and display functions in Nvivo 7.0 software. A coding 
scheme was designed based on literature and transcripts. Data were grouped according to 
relevant codes. Next, the findings from the interviews on the uses of corporate reputation are 
presented. 
 
Findings 
Interview results on value creation  
In general, the experts clearly expressed that value creation is an important part of 
corporate reputation. Experts discussed the importance of the ability to create value for the 
uses of corporate reputation in pharmaceutical companies as follows: 
“Brand value could be considered as a brand reputation that people recognize. 
Employees’ commitment toward this company, in fact, is actually the strength to 
support a brand value from inside out.” (Manager in company F) 
“What we value the most is the remedial effect of the medicine. It is fair to say that 
medication from original pharmaceutical companies is usually more expensive. Lots of 
people believe that an expensive drug guarantees its effects. However, I focus more on 
the efficacy of the medication.”  (Manager in company A) 
 
Additionally, the value created by the firm helps a firm to establish their marketing 
plan. The following comment of an interviewee reflects these points: 
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“A big pharmaceutical company tends to convince customers by its company image 
and value of performance. The medication which comes from a big, famous company 
is always more expensive than medication produced by pharmaceutical companies in 
Taiwan. For doctors and patients, what really matters about a medicine is its remedial 
effects, not its country of origin. International pharmaceutical companies spend lots of 
money on building company images compared with pharmaceutical companies in 
Taiwan.” (Manager in company A) 
 
Another finding suggests that several different aspects of value can be created for the 
customers based on different customer characteristics. However, the managers had different 
opinions about which type of value creation is the most important. The most commonly 
given answer, functional value created by their firm, is the most popular strategy in the 
pharmaceutical company. For others, experiential value creation is an important aspect in 
forming the corporate reputation of Taiwanese pharmaceutical companies. The following 
statement illustrates this: 
“The offshore pharmaceutical companies, compared with local pharmaceutical 
companies in Taiwan, give less focus on the value of medical efficacy. The offshore 
pharmaceutical companies, instead, may focus more on customers’ thoughts toward 
their products. Their marketing strategy emphasizes the value of experience and 
happiness.” (Manager in company I) 
 
Interview results on strategic resources 
The research reveals that a firm with a good reputation has some strategic advantages. 
It is agreed by the experts that the use of corporate reputation as a strategic resource is 
important. A good corporate reputation attracts good salespeople, helps a company to launch 
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its new products into the market, helps a firm to merge with other smaller pharmaceutical 
producers or to expand the market, to co-operate with and add more sales channels to the 
company and aids in raising funds. The following statements illustrate this: 
“A company with a good reputation is more likely to succeed in introducing to the 
market their new product. From sales department’s point of view, product launch can 
easily impress the market if the product is from a reputable company. […] The 
potential meaning of using the corporate reputation as a strategic resource could be 
expanded in breadth and depth beyond its literal meaning.” (Manager in company F) 
“I suppose that good company reputation can boost product sales and push products 
into markets more quickly. A firm’s reputation can affect other substantial elements of 
marketing strategy, including human resources, retailers and product price.” (Manager 
in company I)   
 
Hence, a good corporate reputation can effectively enhance throughout the 
organisation, and also enable a new product’s entry to the market. It makes the firm easier to 
sell products to its customers. Moreover, a good corporate reputation also makes it easier for 
the firm to sell products to distributors. For example: 
“A company can use customer loyalty as a part of a marketing strategy. I can rely on 
the reputation of my company. My company is attractive to distributors because of its 
good reputation. In other words, distributors will be more confident and interested to do 
business with a company with a good reputation.” (Manager in company B) 
 
Interview results on corporate communication 
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The research undertaken reveals that a firm’s corporate reputation encourages greater 
commitment from employees and internal communication within the company. The 
following statement illustrates this: 
“I have spent my most valued 30 years in this company. There must be a reason for me 
to stay for such a long time. And this reason is the commitment to this company. I am 
proud of the company because I was in a reputable company.” (Manager in company 
A) 
 
Moreover, a firm’s corporate reputation cannot only be used to communicate with its 
stakeholders, but also builds the relationship between the firm and its customers. That is, the 
corporate reputation also builds external communication with the stakeholders. An example 
was given by one of the experts, who mentioned about how a firm with a good corporate 
reputation can influence its customers and also make customers have a better perception of 
the company and its FABs (Features, Advantages and Benefits): 
“The ways we use to communicate with consumers includes building a relationship 
between company and consumers. A well-reputed company gains more trust from the 
customers. This helps to strengthen the relationship between the company and the 
customers. If you have a strong relationship with customers, you will have more 
resources to market your products and achieve your sales target.” (Manager in 
company H) 
 
It is important that a good corporate reputation can tighten the relationship between the 
company and its customer via improved communication.  However, some time is needed for 
a customer to recognize a firm as a “well-reputed” firm: 
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“A company with a good reputation can always influence customers’ decisions. But it 
could take a lot of effort for the company to establish its reputation. The establishment 
of company reputation could require 10 or 20 years of hard work.” (Manager in 
company B) 
 “Our firm’s corporate reputation with a good manufacturing history, a reputable 
product experience, helps the communication with our customers.” (Manager in 
company F) 
 
Brand Image Strategy        
Following the data analysis, findings about the brand image strategy are thematically 
divided into brand segmentation, brand differentiation and brand position, (e.g., Chen and 
Otubanjo, 2013; Chen et al., 2015). These are presented sequentially next. 
 
Interview results on brand segmentation 
Segment development is important in implementing a firm’s brand image strategy. 
However, segmentation is based on differentiating the needs of the customer. Similar factors 
of target segments of customers enable managers to implement a strategy, but there are 
different ways of implementing segmentation within one organisation. According to the 
manager in company F: 
A: “I prefer using diseases for market segmentation. I mean that diseases are used for 
identification of niche products. For example, every patient with cancer will visit an 
oncology department. This is a good example of using disease for market segmentation 
because it uses differences between products to introduce a new product. It won’t be 
difficult to identify niche products as long as you think about many different factors, 
not just only one factor.” (Manager in company F) 
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Moreover, some companies use different channels of distribution to implement 
segmentation strategy, such as hospitals, clinics and pharmacies. The following statement 
illustrates this:  
“Market segmentation can be done via pointing out the distribution channels. The large 
corporations have their own hospital channels to promote their products. That is how 
they can produce the best outcome via proper allocation of their staffs and use of the 
existing resources.”  (Manager in company I)   
 
Other interviewees suggested that there are many other factors, such as whether there is 
a focus on R&D, that decide the type of segmentation. Besides R&D, different channels of 
distribution can be the basis of brand segmentation. The following statement illustrates this:  
B: “The distribution channel for these products will be hospitals since the price of our 
products is relatively high. Hospitals normally can accept products with a higher price 
range.” (Manager in company E) 
 
Interview results on brand differentiation 
To enable a good brand image strategy, brand differentiation has to be applied well. 
However, achieving brand differentiation is very difficult in this particular industry. There is 
a standard procedure (bioequivalence and bioavailability, as explained in the following 
paragraph) that has to be followed during production in the pharmaceutical industry. Thus, in 
the end, it is not possible to distinguish between original and generic products. The following 
statement illustrates this: 
“… If the difference does not exceed a certain level, you conclude that there is no 
significant difference between these two products but you still cannot claim these two 
products are exactly the same.” (Manager in company E) 
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Even if it is hard to implement brand differentiation strategy in this industry, there are 
two ways of implementing brand differentiation strategy: product oriented and customer 
based. First, the product packaging can make the company image; this can be behind the 
logic of brand image strategy making. For example: 
“There are so many things to be done to differentiate your drug products, including 
dosage, product features, packaging, drug in tablet or liquid form, flavours, clinical 
evidence and approval certificate by Health Department etc. We can apply and 
combine these products features and the use of end users to differentiate our brand.”  
(Manager in company F) 
“The product package represents a company’s image. It is not limited to real 
packaging. A nice looking package of course can attract consumers to buy your 
products. You can also put a photo of charity events funded by your company such as a 
running event for cancer patients. You can find many charity events or organizations 
overseas.” (Manager in company A) 
 
A common way of differentiation for pharmaceutical products is to make them into 
different forms of a medical product, such as liquid, tablets or capsules. Different forms of 
the medicine enable different brand image strategies to be applied. The following statement 
illustrates this:  
“No one will care about brand differentiation if your drugs and other competitors’ 
drugs are both within legal limits. However, there are definitely differences between 
your products and others. The only job is just you have to know what the difference is 
and how you can show the brand differentiation to your consumers. For example, if 
you feel like making a drug as a tablet, capsule or film coating and if is not easy to get 
the drug to a certain feature, you then turn to make the drug in liquid form, such as 
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syrup or injections. However, a drug in liquid form is normally unstable. That is what 
you can use to promote your drug, just like using a slogan ‘our product as a tablet is 
better and stable’.” (Manager in company E) 
 
In addition to packaging, some creative R&D combine two ingredients into one tablet 
to enable the consumer to use the medical product more easily – thereby creating a 
differentiation:  
“I don’t know whether you have noticed that only few of the modern drug products 
contain only one ingredient. Most of the modern drug products tend to combine two 
ingredients called a ‘combo’.” (Manager in company A) 
 
Second, categorising customers can have an impact on the entire production and 
marketing scheme. The following statement illustrates this: 
“I will differentiate my products for the end users, doctor and pharmacist. No matter 
whether we differentiate our products for the end users or any other ways, we all want 
the same result, which is to influence the customers’ behaviour. I will tend to promote 
sales to the end users and strengthen our aftersales service to achieve this.” (Manager in 
company F) 
 
The findings reveal that there are different ways to implement customer-based brand 
differentiation: 
“Another way is the signing of contracts. We are very flexible in signing sales 
contracts. That will make our sales people easily get the sales contract signed by our 
customers. Our salesman can flexibly change the contract and tailor the contract based 
on their sales volume.…” (Manager in company F) 
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Some other ways of implementing a customer-based differentiation strategy, include 
using low prices, spread word of mouth, and using opinion leaders to lead consumer 
thinking, giving quick results for brand differentiation. For example: 
“The best and most direct method to differentiate your brand name is to create the 
product value by a cheaper price. When your customers can accept your products easily 
and quickly, they will help to promote your product as a cheap and good product via 
word of mouth. We can also differentiate our product by hiring an opinion leader in the 
medical industry to endorse our products with their own good experiences and 
treatment results. Finally, it is a great advantage for products to be able to sell in 7–11 
stores. Then your distribution channel will not be limited to pharmacies. If the products 
can only be sold in a pharmacy, we can only use the end user, such as a doctor, to help 
us to differentiate the product.” (Manager in company I) 
 
Interview results on brand positioning 
One of the most important factors in implementing positioning strategy is price. Some 
companies position their product as a premium product because they have a very good 
corporate image or appear frequently in commercials. This kind of positioning strategy is 
based on the corporate image. A respondent illustrates: 
“A company with a good reputation can also promote their products more easily by 
improving company image and by connecting itself to the distributors. For example, we 
usually advertise in the medical journals or show up at the medical conferences to 
enhance our reputation. A debut conference and a product commercial are often used to 
boost customers’ confidence in a new medical product and to position well this 
product. Thus, it also builds an unseen positioning strategy within customers’ minds.” 
(Manager in company B) 
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Another way to position their product at the high-end market is to use ingredients from 
a certain country. For example, products from the USA, Europe or Taiwan can be positioned 
for the high-end market and sold for a high price: 
“We prefer ingredients for medicine production from Europe and India, and we would 
rather not use ingredients from China. People can find out the differences between 
ingredients from different regions when testing these ingredients. The medical 
ingredients from China may survive testing on effects, but these ingredients always fail 
impurity tests.” (Manager in company A) 
 
Some companies implement their positioning strategy by basing it on medical 
effectiveness. This positioning strategy is based on customer needs: 
“A company needs to take all aspects, such as efficacy of the medicine, of one 
medication into consideration before doing product positioning. Anti-wrinkle products 
with good effects on skin could be an example for product positioning. Medication 
with good efficacy will be recognised as a high-end product, even if producing expense 
of this medication is not high.” (Manager in company B) 
 
However, there are companies, which are more manufacturer-oriented and would rather 
position their products as good quality by focusing on customer relationships. Statements 
from the managers illustrates this: 
“I’d rather do business with small firms. A company is more likely to make the profit 
from the business with small firms, and this sort of business allows the company to 
make bigger profit from the products they have sold.” (Manager in company E) 
“A good post-sale service is required after the value of one product is recognized by 
customers. A good post-sale service is to strengthen customer’s faith in the product 
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value and to influence doctors’ prescriptions. This is to enlarge the market share of a 
single product.” (Manager in company I) 
 
Discussion 
 Despite the importance of corporate reputation, the concept of the uses of corporate 
reputation is not well defined in the brand management literature. In this study, an analysis of 
the uses of corporate reputation and its conceptualizations has been provided. Moreover, the 
dimensions of the construct were found in the literature (Dickson and Ginter, 1987). Even 
there, insufficient empirical research has been done on investigating the uses of corporate 
reputation from the managerial perspective, especially in relation to the brand strategy 
implementation. This study therefore attempted to gain meaningful degrees of understanding 
of the uses of corporate reputation construct by using qualitative interviews with executives. 
The conceptual model arising from the interviews is shown in Figure 1. 
The qualitative findings generally showed that three dimensions of the uses of 
corporate reputation (i.e. value creation, strategic resources and corporate communication) 
are applicable to managers’ brand image strategy implementation for the Taiwanese 
pharmaceutical industry. The findings were somewhat consistent with other studies on brand 
image strategy (Knox and Bickerton, 2003), but extended these studies in several ways.  
Some issues can be observed, as follows: First, the operationalisation of the uses of 
corporate reputation construct was shown to depend on the geographical settings (e.g. 
country, culture, industry, etc.). For instance, when the pharmaceutical managers in Taiwan 
were asked to explain how the brand image strategy is applied, more emphasis was placed on 
sales experiences rather than a holistic brand experience. Findings suggest that the uses of 
corporate reputation are recognised as an important concept in Western countries as well as 
to Taiwanese companies. Taiwanese show a similar understanding about the overall concept 
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to those reported in the literature, but place more weight on different domains in the 
interviews. In addition, the findings reveal that the dimensions and the consequences of the 
uses of corporate reputation may be effectively used in other management and organisational 
areas as well. An example is the applicability of the strategic resources tactics with a firm’s 
corporate reputation. A respondent suggested that the uses of a firm’s reputation would “gain 
the firm more opportunity for strategic alliance or business cooperation”. Based on the 
Taiwan market environment, this argument would be appropriate only for huge generic 
pharmaceutical companies, mainly due to the differences in the corporate strength and a 
combination of each company’s different core values.    
A pharmaceutical company that implements brand segmentation strategy signals that 
the firm has solid and strong marketing capabilities. When such a company achieves brand 
segmentation effectively, it suggests, to a certain level, that it can manage its company 
reputation successfully. For marketing managers in a pharmaceutical company, the reputation 
should be utilised to establish a solid and strong image in its customers’ minds. Specifically, 
the current research highlights that value creation herein pertains to the value created for the 
firm, as (a) cost/sacrifice value, (b) symbolic/expressive value, and (c) experience/hedonic 
value. Cost/sacrifice value suggests that the firm competes by offering economic value, such 
as low prices, value in use, life costs by minimizing psychological investment of customers 
(ease of use, ease of doing business, simplicity, availability, accessibility) (Wong and 
Saunders, 1993). In other words, personal investments of customers (time, effort, energy) are 
minimised and customer risk (personal, technological, strategic) diminished. The 
symbolic/expressive value refers to the organisation that competes using their reputation to 
enhance their self-identity, self-concept, self-worth; by creating personal meaning, or by 
facilitating self-expression (Wong and Saunders, 1993). Finally, experience/hedonic value 
relates to the way in which firms use their reputation to create sensory value or appeal to the 
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senses. That is, the firm may create appropriate emotions (fun, pleasure, excitement, 
relaxation, etc.) in order to facilitate social relationships (bonds, attachments, togetherness) 
and epistemic value (knowledge, novelty, fantasy) (e.g., Wong and Saunders, 1993).  
A pharmaceutical company’s value creation ability can be used as a statement of its 
corporate reputation. It may become known for creating functional value with a high standard 
of product; it may also create a good impression through the use or the purchasing of its 
product or via its customer service; it may also be known for having the long history or 
having an iconic impression in the industry, or for savings the customer’s money or having 
the lowest cost for its product (Hallier-Willi et al., 2014). The value created for the customers 
is judged by the customers to be helpful in their lives. The customers, who benefit from the 
value that a firm has created for them, will thus appreciate the company as reputable and 
trustworthy.  
In summary, this research makes several theoretical contributions. First of all, the 
findings advance current knowledge by adding alternative insights to the uses of corporate 
reputation from top executives. The study adds views on the uses of corporate reputation to 
possible outcomes of brand image strategy. Additionally, relevant mechanisms underlying 
the relationships between the uses of corporate reputation and the design of brand image 
strategy are investigated in a non-Western context. That is, this research illustrates how each 
dimension of the use of corporate reputation affects the design of brand image strategy in the 
pharmaceutical industry in Taiwan. 
 
Managerial implications 
By recognising the effectiveness of the uses of corporate reputation in 
pharmaceuticals and from the brand manager’s perspective, the management team can devise 
their branding and marketing plans more successfully. In order to create an effective brand 
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image strategy, the manager can concentrate on particular aspects of ways to build the firm’s 
reputation (e.g. value creation, strategic resources and corporate communication), in order to 
create effective tools for their brand image strategy. These managers may enhance their 
competitive advantage by using their reputation values related to (a) cost/sacrifice, (b) 
symbolic/expressive, and (c) experience/hedonic, as explained above. 
A firm can apply the following activities to improve its segmentation strategy and 
build best practices: First, a firm should strive to enhance its value-chain activity and make it 
consistent with experiential value creation—for example, integrating the medicinal material 
supply with innovation, R&D, manufacturing, and after-sales service. Second, the firm 
should allocate resources to be more consistent with experiential value creation. Third, the 
firm should try to enhance the customers’ self-identity. The firm should communicate more 
effectively with shareholders and other stakeholders to shape their perceptions about the firm 
and to build customer relationship. Fourth, the firm should negotiate with competitors to take 
advantage of joint resources and to ensure its product suits the market better. The firm should 
also negotiate with the government to affect policies and build important government ties. 
The qualitative data show that when pharmaceutical company managers use value 
creation and corporate communication to implement their brand differentiation strategy, they 
reach their targets more effectively. Firms can implement the strategy in based on emotional 
characteristics, and based on knowledge sharing in order to induce value co-creation of their 
services. Finally, a firm can undertake activities to monitor their best practices in order to 
achieve a better brand positioning strategy. These activities include (1) entering new market 
earlier, (2) managing the marketing system more efficiently, and (3) maintaining customer 
relationships. These activities give the brand a clearer brand image, and provide customers 
with a more thorough understanding of the firm and the brand by effectively transfering the 
product or brand information to the consumers.  
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Conclusion 
 This exploratory qualitative study provides richness of data forming the basis for 
developing the concept of the uses of reputation. The study provided a better understanding 
of the research question: how do Taiwanese pharmaceutical companies use their corporate 
reputation to develop brand image strategy? The interview findings added new knowledge on 
how corporate reputation is used in practice and how the brand strategies operate practically. 
The findings of this qualitative study have addressed the issues of corporate 
communication and corporate branding in the pharmaceutical industry. A pharmaceutical 
company that develops innovative products based on a sound scientific approach usually 
enjoys a high reputation while also producing generic products. The pharmaceutical industry 
faces considerable pressure from ethical groups. Workplace health and safety concerns are 
stressed more highly in the pharmaceutical industry than in any other industry (Brammer and 
Millington, 2005), and this industry has significant social externalities (Brammer and 
Millington, 2005). That is, intangible assets, such as corporate reputation, tend to be more 
important for pharmaceutical companies than for other types of companies. For western-
based theories, the study shows that these are also partially applicable to the Taiwanese 
context. More research is warranted to study the differences, perhaps in a longitudinal study.  
Finally, prior research argues that in addition to a pharmaceutical firm’s corporate 
reputation, corporate branding and communication needs managing explicitly. For example, 
Moss (2007) report that pharmaceutical companies engage in corporate branding issues and 
focus their branding activities on products and product attributes. To manage corporate 
communications efficiently, Dolphin and Ying (2000) suggests that a pharmaceutical 
company must improve their understanding of the potential of branding issues and thus 
ensure consistency of its communication message to a wide range of stakeholders. The 
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present study provides evidence on the possible link between corporate reputation influences 
brand strategies and vice versa. 
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Figure 1 Conceptual Model of the Uses of Reputation and Brand Image Strategy 
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Table 1 Full list of interview questions 
Supporting 
Literature 
Qualitative Questions 
Ludlow (1997); 
Kaplan and Norton 
(2000); Pires and 
Aisbett (2003); 
Ulaga (2001); Priem 
(2007); Payne 
(2002); Kamakura 
and Novak (1992)  
 
1. Can you suggest the characteristics of value creation which tend to encourage 
the setting of brand segmentation strategy? And why?   
2. You, as a brand manager, who is responsible for controlling the quality of a 
brand in the firm to create brand segmentation strategy, what value creation 
characteristics (of the uses of corporate reputation) would you put more 
attention to or would like to invest more? And why? 
3. Can you suggest the characteristics of value creation which tend to encourage 
the setting of brand differentiation strategy? And why?   
4. You, as a brand manager, who is responsible for controlling the quality of a 
brand in the firm to create brand differentiation strategy, what value creation 
characteristics (of the uses of corporate reputation) would you put more 
attention to or would like to invest more? And why? 
5. Can you suggest the characteristics of value creation which tend to encourage 
the setting of brand positioning strategy? And why?   
6. You, as a brand manager, who is responsible for controlling the quality of a 
brand in the firm to create brand positioning strategy, what value creation 
characteristics (of the uses of corporate reputation) would you put more 
attention to or would like to invest more? And why? 
 Birger Wernerfelt 
(1984) 
7. Can you suggest the characteristics of strategic resource which tend to 
encourage the setting of brand segmentation strategy? And why?   
8. You, as a brand manager, who is responsible for controlling the quality of a 
brand in the firm to create brand segmentation strategy, what strategic 
resource characteristics (of the uses of corporate reputation) would you put 
more attention to or would like to invest more? And why? 
9. Can you suggest the characteristics of strategic resource which tend to 
encourage the setting of brand differentiation strategy? And why?   
10. You, as a brand manager, who is responsible for controlling the quality of a 
brand in the firm to create brand differentiation strategy, what strategic 
resource characteristics (of the uses of corporate reputation) would you put 
more attention to or would like to invest more? And why? 
11. Can you suggest the characteristics of strategic resource which tend to 
encourage the setting of brand positioning strategy? And why?   
12. You, as a brand manager, who is responsible for controlling the quality of a 
brand in the firm to create brand positioning strategy, what strategic 
resource characteristics (of the uses of corporate reputation) would you put 
more attention to or would like to invest more? And why? 
Reeves, 1961; 
Ogilvy, 1963;   
Dickson and Ginter, 
1987; Johar and 
Sirgy, 1989; Sirgy, 
1989;   Peltier and 
Schribrowsky, 1997; 
13. Can you suggest the characteristics of corporate communication which tend 
to encourage the setting of brand segmentation strategy? And why?   
14. You, as a brand manager, who is responsible for controlling the quality of a 
brand in the firm to create brand segmentation strategy, what 
communication characteristics (of the uses of corporate reputation) would 
you put more attention to or would like to invest more? And why? 
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Vargo and Lusch, 
2004;    Flint, 2004; 
Hooley et al., 2004; 
Madhavaram et al., 
2005; Nandan, 2005 
 
15. Can you suggest the characteristics of corporate communication which tend to 
encourage the setting of brand segmentation strategy? And why?   
16. You, as a brand manager, who is responsible for controlling the quality of a brand in 
the firm to create brand segmentation strategy, what communication characteristics (of 
the uses of corporate reputation) would you put more attention to or would like to 
invest more? And why? 
17. Can you suggest the characteristics of corporate communication which tend to 
encourage the setting of brand segmentation strategy? And why?   
18. You, as a brand manager, who is responsible for controlling the quality of a brand in 
the firm to create brand segmentation strategy, what communication characteristics (of 
the uses of corporate reputation) would you put more attention to or would like to 
invest more? And why? 
 33 
Table 2 Sample of executives 
 
Intervie
wee 
The 
Respondent 
The Organisation Duration 
(minutes) 
1 Vice Executive 
Officer 
A Taiwanese local pharmaceutical 
manufacturing company (company A) 
90 
2 
 
Sales Manager A Japanese original medicine company 
Taiwan branch (company B) 
120 
3 Chairman A Taiwanese local pharmaceutical 
manufacturing company (company C) 
60 
4 Manager 
(Management) 
A Taiwanese local pharmaceutical 
manufacturing company (company D) 
90 
5 Chief Executive 
Officer 
A Taiwanese local pharmaceutical 
manufacturing company (company E) 
90 
6 
 
Chief Executive 
Officer 
A Taiwanese local pharmaceutical 
manufacturing company (company F) 
90 
7 
 
Chief Executive 
Officer 
 
A commercial agent selling European 
imported raw material medicine and 
local generic medicine (company G) 
120 
8 Marketing 
Department 
Manager 
The largest Taiwanese local 
pharmaceutical manufacturing company 
(company H) 
90 
9 Sales Manager A Japanese original medicine company 
Taiwan branch (company I) 
90 
10 
 
Chairman A B2B marketing company selling 
European imported medicine and local 
generic medicine (company J) 
90 
11 Sales Manager 
 
A leading American original medicine 
company Taiwan branch (company K) 
90 
12 
 
Chairman 
 
A commercial agent selling European 
imported raw material medicine and 
local generic medicine (company L) 
50 
13 
 
Sales Manager A Japanese original medicine company 
Taiwan branch (company M) 
60 
14 
 
Sales Manager A Taiwanese local pharmaceutical 
manufacturing company (company N) 
60 
  
 
